Fox Run Management’s Bausch Health BHC Stock Holding History

Fox Run Management’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-36,787	Closed	-$256K	–	916
2025 Q4	$256K	Buy	+36,787	New	+$242K	0.04%	737
2024 Q4	–	Sell	-12,238	Closed	-$99.9K	–	874
2024 Q3	$99.9K	Sell	12,238 -8,719	-42%	-$57.5K	0.02%	742
2024 Q2	$146K	Buy	+20,957	New	+$159K	0.03%	703
2023 Q1	–	Sell	-14,086	Closed	-$88.5K	–	667
2022 Q4	$88.5K	Sell	14,086 -14,497	-51%	-$101K	0.04%	569
2022 Q3	$197K	Buy	+28,583	New	+$199K	0.08%	483
2021 Q1	–	Sell	-12,965	Closed	-$270K	–	214
2020 Q4	$270K	Buy	+12,965	New	+$242K	0.55%	74
2019 Q4	–	Sell	-28,556	Closed	-$624K	–	387
2019 Q3	$624K	Buy	+28,556	New	+$653K	0.57%	17
2018 Q3	–	Sell	-29,505	Closed	-$686K	–	581
2018 Q2	$686K	Buy	+29,505	New	+$610K	0.22%	146
2016 Q4	–	Sell	-11,800	Closed	-$290K	–	504
2016 Q3	$290K	Buy	+11,800	New	+$305K	0.17%	266

Other funds holding BHC

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

GAM

Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

MFN Partners Boston, Massachusetts $4.77B AUM 72.29% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Fox Run Management's BHC Position: Q1 2026 in Review

Fox Run Management sold out of Bausch Health (BHC) in Q1 2026, closing a stake of 36,787 shares — an estimated $256K sold.

Fox Run Management first reported a position in BHC in Q3 2016 and held it in 9 quarters. The position peaked at $686K in Q2 2018. 227 funds tracked by Wall St. Rank hold BHC as of Q1 2026.

Fox Run Management reported no remaining Bausch Health position as of Q1 2026 after selling out during the quarter.
Fox Run Management sold 36,787 Bausch Health shares in Q1 2026, an estimated $256K.
Fox Run Management first reported a position in Bausch Health in Q3 2016 and held it in 9 quarters.
Fox Run Management's Bausch Health position peaked at $686K in Q2 2018.
227 funds tracked by Wall St. Rank held Bausch Health as of Q1 2026.

Based on Fox Run Management's 13F filing for Q1 2026, filed 12 May 2026.